Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
V. Veerapaneni (mysore, India), J. Bs (mysore, India), C. S.K (mysore, India), L. K.S (mysore, India), K. Sivakoti (mysore, India), R. Tirumulappa (mysore, India), M. P.A (mysore, India). Serum Club cell16 levels as a biomarker in tobacco-smoke COPD and biomass-smoke COPD. 5479

Member's Comments

No comment yet.

Related content which might interest you: Serum BNP levels in COPD, asthma-COPD-overlap-syndrome, smokers and never-smokers Source: International Congress 2016 – Systemic biomarkers Year: 2016 Elevated serum IL-8: a biomarker indicating exacerbation-prone COPD Source: International Congress 2017 – COPD biomarkers Year: 2017 Increased serum endotoxin levels as biomarker in acute exacerbations of COPD. Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Blood biomarkers in asthma and COPD Source: International Congress 2017 – PG6 Assessing and monitoring airway inflammation in asthma and chronic obstructive pulmonary disease Year: 2017 Plasma biomarkers and response to therapy at exacerbation of COPD Source: Eur Respir J 2007; 30: Suppl. 51, 39s Year: 2007 Fibrinogen and CRP biomarkers in patients with exacerbation of COPD group C and D Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Serum periostin in patients hospitalized for COPD exacerbations Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap Source: Annual Congress 2013 –Is it really asthma? Year: 2013 Serum G-CSF is a non-invasive biomarker classifying bacterial/neutrophilic COPD exacerbations Source: Virtual Congress 2020 – Phenotypes of asthma and COPD Year: 2020 Sputum biomarkers of inflammation in smokers and subjects with COPD Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Metabolomics identifies biomarkers of exacerbations in smokers with and without COPD Source: Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases Year: 2020 Prevalence of exacerbation in COPD patients with chronic bronchitis and association with elevated serum inflammatory biomarkers Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Visfatin as a possible serum biomarker in COPD Source: International Congress 2019 – Crosstalk in chronic pulmonary diseases Year: 2019 Differences in plasma and sputum biomarkers between COPD and COPD–asthma overlap Source: Eur Respir J 2014; 43: 421-429 Year: 2013 Serum vitamin D3 level correlates with FEV1 in patients with advanced COPD Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 Effects of erdosteine on serum biomarker concentrations at COPD exacerbation Source: Annual Congress 2010 - Novel anti-inflammatory agents for airway disease Year: 2010 Serum sirtuin-1 is reduced in COPD Source: International Congress 2016 – Systemic biomarkers Year: 2016 Association of serum pneumoproteins with clinical course of COPD Source: International Congress 2017 – COPD biomarkers Year: 2017 Serum SP-A and SP-D levels in patients admitted to the hospital with acute COPD exacerbation Source: International Congress 2016 – Inflammatory biomarkers in airway diseases Year: 2016 Analysis of serum prohepcidin and hepcidin levels in COPD patients by stages and by patient cathegory Source: Annual Congress 2013 –COPD treatment Year: 2013